Filing Flows › GeoVax Labs (GOVX) › Recalls, complaints & regulation
GeoVax Labs (GOVX): clinical trials
GeoVax Labs (GOVX) beyond its filings: 1 active clinical trial.
GeoVax Labs' latest quarter
GeoVax Labs, Q2 2025: revenue $852K (+184% year over year), operating margin -635.8%, net loss $5.4M, operating cash flow −$4.3M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does GeoVax Labs have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.